Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecobalamin Combined With Anti-VEGF for Retinal Vein Occlusion
NCT07133438Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Aug 2025
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of mecobalamin in retinal vein occlusion (RVO), macular edema, sponsored by First Affiliated Hospital of Chongqing Medical University. Started Aug 2025; status: recruiting.
02
Drugs
mecobalamin
03
Conditions
retinal vein occlusion (RVO)macular edema
Beyond the preview
Go deeper on NCT07133438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07133438.